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bstract
A simple and efficient synthesis of 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine derivatives was achieved in one pot via  a four-
omponent cyclocondensation of aromatic aldehydes, 1,3-indanedione, β-ketoesters and ammonium acetate in the presence of
ribromomelamine (TBM) as the catalyst under neat conditions. The present approach offers several advantages, such as shorter
eaction times, higher yields, low cost, simple work-up and easy purification compared with the other available methods.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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.  Introduction
Many biologically important molecular scaffolds can
e easily synthesized from readily available starting
aterials with the aid of multi-component reactions
MCRs). MCRs allow the construction of several bonds
n a single operation and are gaining considerable impor-
ance as one of the most powerful emerging synthetic
ools for the creation of molecular complexity and diver-
ity. Moreover, MCRs offer the advantage of simplicity
nd synthetic efficiency over conventional chemical∗ Corresponding author. Tel.: +91 9944093020.
E-mail address: smansoors2000@yahoo.co.in (S.S. Mansoor).
eer review under responsibility of Taibah University.
ttp://dx.doi.org/10.1016/j.jtusci.2015.10.003
658-3655 © 2015 The Authors. Production and hosting by Elsevier B.V. on 
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ne; 1,3-Indanedione
reactions. Therefore, the search and discovery of new
MCRs, along with a full exploitation of the already
known MCRs, are of considerable interest [1–4].
The indenopyridine nucleus is present in the 4-
azafluorenone group of alkaloids. 4-Azafluorenones
(5H-Indeno[1,2-b]pyridin-5-ones) are naturally occur-
ring alkaloids isolated from the root of the plant
Polyalthia debilis  (Pierre) belonging to the family of
Annonaceae. As the core structural unit in a wide
range of natural products, azafluorenone has recently
attracted much research [5]. Representative mem-
bers of this class of compounds are onychine (a),
7-methoxy onychine (b), cyathocaline (c) and isour-
suline (d) (Fig. 1). Azafluorenone derivatives have
been reported to possess aldose reductase inhibi-behalf of Taibah University. This is an open access article under the
tion activity [6] and cytotoxic activity [7]. The roots
of Polyalthia  cerasoides  have led to the isolation
of the new compound, 6,8-dihydroxy-7-methoxy-1-
methyl-azafluorenone. This compound exhibited potent
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Fig. 1. Some naturally occurring bioactive azafluorenones.
cytotoxic activities [8]. The structure-activity rela-
tionships of azafluorenone and azaanthraquinone as
antimicrobial compounds were reported, and correla-
tions among reduction potential, hydrophobicity, and
antimicrobial activity were discussed [9]. Hydrogenated
indenopyridines have valuable therapeutic uses [10]
because they lower serum lipids, particularly trigly-
cerides, and are used for the therapy of primary
hyperlipidaemias and certain other hyperlipidaemias.
They also have potential antidepressant activity [11].
Due to their crucial importance in chemistry, biology and
industry, a general and flexible method for the prepara-
tion of azafluorenones is important.
According to the literature, several synthetic methods
have been developed for the construction of these types
of fused heterocycles involving the condensation of
aldehydes, 1,3-indandione or 1-indenone and aromatic
ketones in the presence of ammonium acetate under
microwave irradiation [12] and a novel three-component
[5+1] heterocyclization leading to the synthesis of
2-azafluorenone and its polyfunctionalisations [13]. Sev-
eral indeno[1,2-b]pyridine derivatives are synthesized
by grinding [14] using 2,2,2-trifluoroethanol as the sol-
vent [15], using L-proline (15 mol%) as the catalyst [16],
by the Pummerer reaction of imidosulfoxides [17], using
ceric ammonium nitrate as the catalyst [18] and a Pd(0)-
catalyzed cross-coupling reaction [19]. 5-Oxo-1H-4,5-
dihy-droindeno[1,2-b]pyridines have been synthesized
by the condensation of 2-arylideneindane-1,3-diones
with β-aminocrotonates in refluxing acetic acid [20]. A
green method for the synthesis of indeno[2,1-c]pyridines
in ionic liquid catalyzed by malononitrile has been
developed [21]. Recently, an MCR of indane-1,3-dione,
an aldehyde and an amine containing an aromatic com-
pound leading to the formation of indenopyridine-basedScheme 1. Synthesis of 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine
derivatives.
heterocyclic scaffolds has been investigated [22].
However, the requirement of high temperatures, the
occurrence of side reactions, low yields, expensive
catalysts and long reaction time limit the use of these
methods. Therefore, the search for a better method for
the synthesis of indenopyridines is of prime importance.
During recent years, tribromomelamine (TBM) has
received considerable attention as an inexpensive and
nontoxic catalyst for a series of organic transformations
[23–26] due to its cost-effectiveness, eco-friendly
nature, easy handling, high reactivity and simple work-
up procedures. TBM is reported as a homogeneous and
non-hygroscopic solid catalyst in organic transforma-
tions, such as the synthesis of the trimethyl silylation of
hydroxyl groups with 1,1,1,3,3,3-hexamethyldisilazane
(HMDS) [23], the synthesis of 2-aryl thiazolines
[24], the synthesis of 1-amidoalkyl-2-naphthols [25]
and acetylation and formylation reactions of alcohols
[26]. We have also synthesized a series of 7-aryl-
8H-benzo[h]indeno[1,2-b]quinoline-8-one derivatives
using tribromomelamine [27]. TBM is stable under
a variety of different reaction conditions, including
acidic and basic conditions. Note that TBM is produced
via a facile and clean process that does not require a
complicated work-up procedure.
In the course of our study aimed at improving the
eco-compatibility of certain organic processes for the
synthesis of biologically active organic compounds by
multi-component reactions [28–32], we developed an
efficient synthesis of 4-aryl-4,5-dihydro-1H-indeno[1,2-
b]pyridine derivatives using TBM as an efficient,
novel homogeneous catalyst via  the cyclocondensation
reaction of aromatic aldehydes, 1,3-indanedione, β-
ketoesters and ammonium acetate under neat conditions
at 70 ◦C (Scheme 1).
2.  Experimental2.1.  Chemicals  and  analysis
The chemicals used were purchased from Merck,
Fluka and Aldrich Chemical Companies. All of the
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7.50–7.76 (m, 4H, Ar-H) ppm; C NMR (125 MHz,
DMSO-d6) δ: 14.4, 18.4, 36.0, 50.5, 105.8, 108.7, 118.4,Melamine Tribromomelamine (TBM)
Scheme 2. Preparation of tribromomelamine (TBM).
ields refer to isolated products unless otherwise stated.
H NMR (500 MHz) and 13C NMR (125 MHz) spec-
ra were obtained using a Bruker DRX-500 Avance
pectrometer at ambient temperature using TMS as the
nternal standard. FT-IR spectra were obtained as KBr
iscs on a Shimadzu spectrometer. Mass spectra were
etermined on a Varion-Saturn 2000 GC-MS instrument.
lemental analysis was measured using a Perkin Elmer
400 CHN elemental analyser flowchart.
.2.  Preparation  of  tribromomelamine
Tribromomelamine (TBM) is readily prepared by the
ropwise addition of Br2 to a 5 M NaOH mixture of
elamine at room temperature (Scheme 2) [23].
.2.1. General  procedure  for  the  synthesis  of
-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine
erivatives  (4a-r)
A mixture of aromatic aldehyde 1  (1 mmol),
,3-indanedione 2  (1 mmol), ethylacetoacetate or methy-
acetoacetate 3 (1 mmol), ammonium acetate (1.5 mmol)
nd tribromomelamine (10 mol%) was heated to 70 ◦C
or 8–18 min. The reaction process was monitored by
hin layer chromatography (TLC). The resultant solid
aterial was washed thoroughly with water to remove
ny unreacted ammonium acetate and was air-dried
vernight. Then, the material was purified by silica
el column chromatography using ethyl acetate and n-
exane as eluents to give compounds 4a-r  in high yields
Scheme 1). The IR, 1H NMR, 13C NMR, mass and ele-
ental analysis data of the synthesized compounds are
iven below.
.3.  Spectral  data  for  the  synthesized  compounds
4a-r)
.3.1.  2-Methyl-4-phenyl-5-oxo-4,5-dihydro-1H-
ndeno-[1,2-b]pyridine-3-carboxylic  acid  ethyl  ester
4a)
−1 1IR (KBr, cm ): 3256, 2960, 1704, 1662, 1553; H
MR (500 MHz, DMSO-d6) δ:  1.11 (t, J  = 7.2 Hz, 3H,
H3), 2.42 (s, 3H, CH3), 4.05 (q, J  = 7.2 Hz, 2H), 4.75
s, 1H), 6.88 (s, 1H, NH), 7.14–7.30 (m, 5H, Ar-H),rsity for Science 10 (2016) 709–717 711
7.42–7.66 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.0, 18.1, 35.9, 51.0, 105.1, 109.0, 118.0,
121.3, 127.8, 129.0, 130.3, 131.0, 132.7, 133.6, 136.2,
144.7, 145.6, 154.0, 168.2, 191.5 ppm; MS(ESI): m/z
346.14 (M+H)+; Anal. calcd. for C22H19NO3: C, 76.50;
H, 5.54; N, 4.06%. Found: C, 76.38; H, 5.49; N, 4.02%.
2.3.2. 2-Methyl-4-(4-chlorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4b)
IR (KBr, cm−1): 3248, 2968, 1700, 1655, 1560; 1H
NMR (500 MHz, DMSO-d6) δ:  1.04 (t, J  = 7.2 Hz, 3H,
CH3), 2.51 (s, 3H, CH3), 4.00 (q, J = 7.2 Hz, 2H), 4.88
(s, 1H), 6.82 (s, 1H, NH), 7.16 (d, J  = 8.0 Hz, 2H, Ar-
H), 7.32 (d, J  = 8.0 Hz, 2H, Ar-H), 7.48–7.70 (m, 4H,
Ar-H) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.2,
17.9, 35.8, 51.1, 105.6, 109.1, 118.5, 121.2, 127.9, 129.4,
130.5, 131.1, 132.5, 133.2, 136.3, 144.6, 145.4, 153.4,
168.0, 190.7 ppm; MS(ESI): m/z  380.1 (M+H)+; Anal.
calcd. for C22H18ClNO3: C, 69.57; H, 4.78; N, 3.69%.
Found: C, 69.50; H, 4.72; N, 3.63%.
2.3.3. 2-Methyl-4-(3-bromophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4c)
IR (KBr, cm−1): 3253, 2965, 1705, 1653, 1568; 1H
NMR (500 MHz, DMSO-d6) δ:  1.06 (t, J  = 7.2 Hz, 3H,
CH3), 2.55 (s, 3H, CH3), 4.02 (q, J = 7.2 Hz, 2H), 4.92
(s, 1H), 6.99 (s, 1H, NH), 7.19–7.36 (m, 4H, Ar-H),
7.47–7.69 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.2, 17.8, 36.4, 50.8, 105.7, 109.0, 118.3,
121.4, 127.8, 129.2, 130.2, 130.9, 132.3, 133.5, 135.9,
144.4, 145.8, 154.1, 168.1, 191.3 ppm; MS(ESI): m/z
424.05 (M+H)+; Anal. calcd. for C22H18BrNO3: C,
62.28; H, 4.28; N, 3.30%. Found: C, 62.21; H, 4.23;
N, 3.25%.
2.3.4.  2-Methyl-4-(3-nitrophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4d)
IR (KBr, cm−1): 3257, 2970, 1710, 1664, 1548; 1H
NMR (500 MHz, DMSO-d6) δ:  1.10 (t, J  = 7.2 Hz, 3H,
CH3), 2.40 (s, 3H, CH3), 4.04 (q, J = 7.2 Hz, 2H), 5.02
(s, 1H), 6.94 (s, 1H, NH), 7.15–7.30 (m, 4H, Ar-H),
13120.9, 128.2, 129.6, 130.4, 130.9, 132.1, 133.2, 135.8,
144.5, 145.7, 153.7, 167.7, 190.8 ppm; MS(ESI): m/z
391.12 [M+H+; Anal. calcd. for C22H18N2O5: C, 67.69;
H, 4.65; N, 7.18%. Found: C, 67.57; H, 4.60; N, 7.19%.
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2.3.5.  2-Methyl-4-(4-methylphenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4e)
IR (KBr, cm−1): 3266, 2974, 1713, 1660, 1549; 1H
NMR (500 MHz, DMSO-d6) δ:  1.02 (t, J = 7.2 Hz, 3H,
CH3), 2.12 (s, 3H, CH3), 2.48 (s, 3H, CH3), 4.04 (q,
J = 7.2 Hz, 2H), 5.07 (s, 1H), 6.87 (s, 1H, NH), 7.19
(d, J = 8.2 Hz, 2H, Ar-H), 7.38 (d, J  = 8.2 Hz, 2H, Ar-
H), 7.52–7.71 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.1, 17.6, 18.4, 36.4, 50.3, 106.1, 108.7,
118.2, 120.8, 128.0, 128.9, 130.3, 131.1, 132.2, 133.5,
136.4, 144.4, 145.5, 154.2, 167.5, 191.0 ppm; MS(ESI):
m/z 360.15 (M+H)+; Anal. calcd. for C23H21NO3: C,
76.86; H, 5.89; N, 3.90%. Found: C, 76.84; H, 5.83; N,
3.88%.
2.3.6. 2-Methyl-4-(4-methoxyphenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4f)
IR (KBr, cm−1): 3250, 2969, 1704, 1667, 1565; 1H
NMR (500 MHz, DMSO-d6) δ:  1.01 (t, J = 7.2 Hz, 3H,
CH3), 2.48 (s, 3H, CH3), 3.52 (s, 3H, OCH3), 4.07 (q,
J = 7.2 Hz, 2H), 4.90 (s, 1H), 6.94 (s, 1H, NH), 7.11
(d, J = 8.2 Hz, 2H, Ar-H), 7.33 (d, J  = 8.2 Hz, 2H, Ar-
H), 7.42–7.68 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.6, 18.7, 35.9, 50.4, 53.2, 106.3, 108.6,
118.9, 120.7, 128.0, 129.2, 130.0, 131.2, 132.2, 133.4,
136.3, 144.6, 145.6, 153.7, 167.4, 190.7 ppm; MS(ESI):
m/z 376.15 (M+H)+; Anal. calcd. for C23H21NO4: C,
73.58; H, 5.64; N, 3.73%. Found: C, 73.53; H, 5.60; N,
3.71%.
2.3.7. 2-Methyl-4-(2-chlorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4g)
IR (KBr, cm−1): 3254, 2966, 1711, 1657, 1567; 1H
NMR (500 MHz, DMSO-d6) δ:  1.12 (t, J = 7.2 Hz, 3H,
CH3), 2.52 (s, 3H, CH3), 4.01 (q, J  = 7.2 Hz, 2H), 4.85
(s, 1H), 6.87 (s, 1H, NH), 7.21–7.39 (m, 4H, Ar-H),
7.49–7.74 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.5, 18.4, 35.7, 50.8, 106.3, 108.8, 118.7,
120.6, 128.3, 129.1, 130.2, 130.8, 132.4, 133.3, 136.2,
145.0, 145.5, 154.0, 167.9, 190.6 ppm; MS(ESI): m/z
380.1 (M+H)+; Anal. calcd. for C22H18ClNO3: C, 69.57;
H, 4.78; N, 3.69%. Found: C, 69.47; H, 4.70; N, 3.61%.
2.3.8. 2-Methyl-4-(4-ﬂuorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4h)
IR (KBr, cm−1): 3258, 2956, 1712, 1659, 1555; 1H
NMR (500 MHz, DMSO-d6) δ:  1.09 (t, J = 7.2 Hz, 3H,
CH3), 2.44 (s, 3H, CH3), 4.00 (q, J  = 7.2 Hz, 2H), 4.84rsity for Science 10 (2016) 709–717
(s, 1H), 6.93 (s, 1H, NH), 7.10 (d, J  = 8.1 Hz, 2H, Ar-
H), 7.30 (d, J  = 8.1 Hz, 2H, Ar-H), 7.40–7.73 (m, 4H,
Ar-H) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.3,
18.5, 36.0, 51.0, 105.9, 108.7, 118.5, 120.9, 128.0, 129.3,
130.0, 130.8, 132.6, 133.5, 135.8, 145.2, 145.7, 154.4,
167.8, 190.9 ppm; MS(ESI): m/z  364.13 (M+H)+; Anal.
calcd. for C22H18FNO3: C, 72.72; H, 4.99; N, 3.85%.
Found: C, 72.63; H, 4.92; N, 3.84%.
2.3.9. 2-Methyl-4-(4-nitrophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4i)
IR (KBr, cm−1): 3244, 2955, 1701, 1663, 1556; 1H
NMR (500 MHz, DMSO-d6) δ:  1.04 (t, J  = 7.2 Hz, 3H,
CH3), 2.47 (s, 3H, CH3), 4.06 (q, J = 7.2 Hz, 2H), 4.99
(s, 1H), 6.91 (s, 1H, NH), 7.13 (d, J  = 8.2 Hz, 2H, Ar-
H), 7.35 (d, J  = 8.2 Hz, 2H, Ar-H), 7.47–7.72 (m, 4H,
Ar-H) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.2,
18.2, 36.1, 51.2, 106.0, 108.8, 118.9, 120.7, 128.1, 129.4,
130.2, 130.9, 132.2, 133.7, 135.9, 145.1, 145.9, 153.7,
168.2, 190.9 ppm; MS(ESI): m/z  402 (M+H)+; Anal.
calcd. for C22H18N2O5: C, 60.30; H, 2.87; N, 10.05%.
Found: C, 60.22; H, 2.85; N, 10.03%.
2.3.10. 2-Methyl-4-(2-ﬂuorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4j)
IR (KBr, cm−1): 3243, 2963, 1713, 1664, 1564; 1H
NMR (500 MHz, DMSO-d6) δ:  1.03 (t, J  = 7.2 Hz, 3H,
CH3), 2.49 (s, 3H, CH3), 4.08 (q, J = 7.2 Hz, 2H), 4.92
(s, 1H), 6.83 (s, 1H, NH), 7.17–7.35 (m, 4H, Ar-H),
7.51–7.73 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.7, 18.0, 36.2, 50.9, 106.3, 109.1,
118.6, 120.6, 127.9, 129.7, 130.1, 130.9, 132.1, 133.9,
135.8, 145.2, 145.9, 153.6, 168.0, 190.5 ppm; MS(ESI):
m/z 364.13 (M+H)+; Anal. calcd. for C22H18FNO3: C,
72.72; H, 4.99; N, 3.85%. Found: C, 72.66; H, 4.90; N,
3.81%.
2.3.11. 2-Methyl-4-(3-chlorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid ethyl  ester  (4k)
IR (KBr, cm−1): 3256, 2952, 1715, 1661, 1565; 1H
NMR (500 MHz, DMSO-d6) δ:  1.10 (t, J  = 7.2 Hz, 3H,
CH3), 2.55 (s, 3H, CH3), 4.08 (q, J = 7.2 Hz, 2H), 5.04
(s, 1H), 6.85 (s, 1H, NH), 7.16–7.34 (m, 4H, Ar-H),
137.50–7.69 (m, 4H, Ar-H) ppm; C NMR (125 MHz,
DMSO-d6) δ: 14.0, 18.3, 36.0, 50.8, 106.3, 109.0, 118.6,
121.0, 127.8, 129.6, 130.3, 130.8, 132.3, 133.7, 135.7,
144.9, 145.5, 153.5, 167.9, 191.3 ppm; MS(ESI): m/z
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80.1 (M+H)+; Anal. calcd. for C22H18ClNO3: C, 69.57;
, 4.78; N, 3.69%. Found: C, 69.53; H, 4.74; N, 3.66%.
.3.12. 2-Methyl-4-(4-bromophenyl)-5-oxo-4,5-
ihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
cid ethyl  ester  (4l)
IR (KBr, cm−1): 3258, 2972, 1707, 1655, 1561; 1H
MR (500 MHz, DMSO-d6) δ:  1.07 (t, J  = 7.2 Hz, 3H,
H3), 2.52 (s, 3H, CH3), 4.02 (q, J  = 7.2 Hz, 2H), 5.09
s, 1H), 6.97 (s, 1H, NH), 7.15 (d, J  = 8.0 Hz, 2H, Ar-
), 7.39 (d, J = 8.0 Hz, 2H, Ar-H), 7.48–7.68 (m, 4H,
r-H) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.2,
7.8, 36.1, 50.9, 106.2, 108.7, 118.5, 121.1, 127.8, 129.6,
30.3, 131.3, 132.1, 133.4, 136.0, 144.9, 145.7, 154.9,
67.7, 190.7 ppm; MS(ESI): m/z  424.05 (M+H)+; Anal.
alcd. for C22H18BrNO3: C, 62.28; H, 4.28; N, 3.30%.
ound: C, 62.19; H, 4.26; N, 3.27%.
.3.13. 2-Methyl-4-phenyl-5-oxo-4,5-dihydro-1H-
ndeno-[1,2-b]pyridine-3-carboxylic  acid  methyl
ster (4m)
IR (KBr, cm−1): 3252, 2961, 1702, 1666, 1551; 1H
MR (500 MHz, DMSO-d6) δ:  2.44 (s, 3H, CH3), 3.48
s, 3H, OCH3), 4.78 (s, 1H), 6.81 (s, 1H, NH), 7.15–7.31
m, 5H, Ar-H), 7.54–7.73 (m, 4H, Ar-H) ppm; 13C NMR
125 MHz, DMSO-d6) δ: 14.7, 36.7, 51.2, 106.4, 110.7,
18.0, 122.1, 127.0, 129.3, 130.0, 131.1, 132.7, 133.4,
37.0, 145.0, 145.7, 154.0, 168.3, 192.0 ppm; MS(ESI):
/z 332.12 (M+H)+; Anal. calcd. for C21H17NO3: C,
6.12; H, 5.17; N, 4.23%. Found: C, 76.04; H, 5.12; N,
.20%.
.3.14. 2-Methyl-4-(4-nitrophenyl)-5-oxo-4,5-
ihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
cid methyl  ester  (4n)
IR (KBr, cm−1): 3249, 2968, 1700, 1658, 1564; 1H
MR (500 MHz, DMSO-d6) δ:  2.42 (s, 3H, CH3), 3.55
s, 3H, OCH3), 4.83 (s, 1H), 6.93 (s, 1H, NH) 7.19 (d,
 = 8.0 Hz, 2H, Ar-H), 7.30 (d, J  = 8.0 Hz, 2H, Ar-H),
.55–7.77 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
MSO-d6) δ: 14.5, 36.5, 51.3, 106.6, 109.7, 118.5,
22.4, 127.8, 129.7, 130.7, 131.3, 132.6, 133.0, 136.7,
44.9, 145.5, 154.9, 168.4, 191.7 ppm; MS(ESI): m/z
77.11 (M+H)+; Anal. calcd. for C21H16N2O5: C, 67.02;
, 4.28; N, 7.44%. Found: C, 66.95; H, 4.22; N, 7.37%.
.3.15. 2-Methyl-4-(4-methylphenyl)-5-oxo-4,5-
ihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
cid methyl  ester  (4o)
IR (KBr, cm−1): 3256, 2957, 1713, 1659, 1563; 1H
MR (500 MHz, DMSO-d6) δ:  2.16 (s, 3H, CH3), 2.39
s, 3H, CH3), 3.45 (s, 3H, OCH3), 4.74 (s, 1H), 6.93rsity for Science 10 (2016) 709–717 713
(s, 1H, NH), 7.11 (d, J = 8.0 Hz, 2H, Ar-H), 7.29 (d,
J = 8.0 Hz, 2H, Ar-H), 7.50–7.69 (m, 4H, Ar-H) ppm;
13C NMR (125 MHz, DMSO-d6) δ: 14.2, 17.5, 37.1,
50.7, 106.2, 108.7, 118.7, 122.6, 127.4, 129.6, 130.6,
131.7, 132.1, 133.8, 137.3, 144.5, 145.2, 154.5, 167.9,
192.3 ppm; MS(ESI): m/z  346.16 (M+H)+; Anal. calcd.
for C22H19NO3: C, 76.50; H, 5.54; N, 4.06%. Found: C,
76.44; H, 5.50; N, 4.01%.
2.3.16.  2-Methyl-4-(4-chlorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid methyl  ester  (4p)
IR (KBr, cm−1): 3258, 2963, 1714, 1655, 1555; 1H
NMR (500 MHz, DMSO-d6) δ:  2.48 (s, 3H, CH3), 3.47
(s, 3H, OCH3), 4.79 (s, 1H), 6.89 (s, 1H, NH), 7.17 (d,
J = 8.0 Hz, 2H, Ar-H), 7.37 (d, J = 8.0 Hz, 2H, Ar-H),
7.58–7.77 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.3, 36.8, 50.8, 106.3, 109.3, 118.3,
121.8, 127.3, 129.4, 130.0, 131.6, 132.3, 133.7, 136.8,
144.2, 145.4, 154.3, 167.8, 191.6 ppm; MS(ESI): m/z
366.10 (M+H)+; Anal. calcd. for C21H16ClNO3: C,
68.95; H, 4.41; N, 3.83%. Found: C, 68.88; H, 4.37;
N, 3.77%.
2.3.17.  2-Methyl-4-(4-bromophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid methyl  ester  (4q)
IR (KBr, cm−1): 3260, 2962, 1703, 1667, 1547; 1H
NMR (500 MHz, DMSO-d6) δ:  2.50 (s, 3H, CH3), 3.52
(s, 3H, OCH3), 4.80 (s, 1H), 6.91 (s, 1H, NH), 7.14 (d,
J = 8.0 Hz, 2H, Ar-H), 7.30 (d, J = 8.0 Hz, 2H, Ar-H),
7.56–7.71 (m, 4H, Ar-H) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.9, 36.6, 50.6, 106.2, 110.0, 118.6,
121.7, 127.8, 129.6, 130.6, 131.3, 132.6, 133.5, 136.5,
145.1, 145.6, 155.2, 168.0, 190.9 ppm; MS(ESI): m/z
410.01 (M+H)+; Anal. calcd. for C21H16BrNO3: C,
61.48; H, 3.93; N, 3.41%. Found: C, 61.41; H, 3.90;
N, 3.37%.
2.3.18.  2-Methyl-4-(3-chlorophenyl)-5-oxo-4,5-
dihydro-1H-indeno-[1,2-b]pyridine-3-carboxylic
acid methyl  ester  (4r)
IR (KBr, cm−1): 3254, 2969, 1708, 1660, 1562; 1H
NMR (500 MHz, DMSO-d6) δ:  2.47 (s, 3H, CH3), 3.46
(s, 3H, OCH3), 4.75 (s, 1H), 6.87 (s, 1H, NH), 7.09–7.27
(m, 4H, Ar-H), 7.48–7.66 (m, 4H, Ar-H) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 14.8, 36.5, 51.0, 106.7, 108.9,
118.4, 122.0, 128.0, 129.5, 130.5, 131.8, 132.3, 133.5,
137.4, 144.7, 145.8, 155.4, 167.8, 191.3 ppm; MS(ESI):
m/z 366.10 (M+H)+; Anal. calcd. for C21H16ClNO3: C,
68.95; H, 4.41; N, 3.83%. Found: C, 68.86; H, 4.39; N,
3.78%.
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Table 1
Optimization of reaction conditions for the synthesis of 4b.a
Entry Catalyst Amount (mol%) Solvent Temperature (◦C) Time (min) Yield (%)b
1 TBM 10 1,4-Dioxane Reflux 60 55
2 TBM 10 CH3CN Reflux 60 52
3 TBM 10 MeOH Reflux 60 73
4 TBM 10 EtOH Reflux 60 79
5 TBM 10 CHCl3 Reflux 60 37
6 TBM 10 Solvent-free 70 8 97
7 TBM 10 Solvent-free rt 8 39
8 TBM 10 Solvent-free 50 8 54
9 TBM 10 Solvent-free 60 8 72
10 TBM 10 Solvent-free 80 8 96
11 TBM 0 Solvent-free 70 8 12
12 TBM 2 Solvent-free 70 8 39
13 TBM 5 Solvent-free 70 8 53
14 TBM 15 Solvent-free 70 8 97
15 PFPAT 10 Solvent-free 70 8 42
16 LiBr 10 Solvent-free 70 8 31
17 p-TSA 10 Solvent-free 70 8 59
a Reaction conditions: 4-chlorobenzaldehyde (1 mmol), 1,3-indanedione (1 mmol), ethyl acetoacetate (1 mmol) and ammonium acetate (1.5 mmol),
solvent 5 mL.
b Isolated yields.
3.  Results  and  discussion
In this study, we report an efficient one-pot synthesis
of 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine deriva-
tives from four components via  the coupling of aromatic
aldehydes, alkyl acetoacetate, β-keto compounds and
ammonium acetate in the presence of a catalytic amount
of TBM under solvent-free conditions at 70 ◦C in excel-
lent yield after a short reaction time.
In an initial attempt, 4-chlorobenzaldehydes
(1 mmol), 1,3-indanedione (1 mmol), ethyl acetoacetate
(1 mmol) and ammonium acetate (1.5 mmol) as a
model reaction was conducted in the presence of TBM
(10 mol%) with various solvents, such as 1,4-dioxane,
CH3CN, CH3OH, C2H5OH, and CHCl3, under reflux
conditions (Table 1, entries 1–5). The reaction was
performed in the absence of solvent at 70 ◦C (Table 1,
entry 6). The results indicated that the solvents had
a significant effect on the product yield. The best
conversion was observed when the reaction was per-
formed under solvent-free conditions at 70 ◦C (Table 1,
entry 6).
To further optimize the reaction yield, we attempted
to perform the experiments at room temperature, 50,
60, 70 and 80 ◦C (Table 1, entries 6–10). It was
observed that a lower reaction temperature led to a
lower yield. As shown in Table 1, we found that a
high temperature could improve the reaction yield. With
these results in hand, we selected solvent-free condi-
tions for the one-pot reaction of aromatic aldehydes(1 mmol), 1,3-indanedione (1 mmol), ethylacetoacetate/
methylacetoacetate (1 mmol) and ammonium acetate to
give the corresponding substituted 4-aryl-4,5-dihydro-
1H-indeno[1,2-b]pyridine derivatives at 70 ◦C (Table 1,
entry 6). When 0, 2, 5, 10 and 15 mol% of TBM were
used, the yields were 12%, 39%, 53%, 97% and 97%,
respectively, at 70 ◦C (Table 1, entries 6 and 11–14). Uti-
lizing 15 mol% of TBM did not significantly increase the
yield (Table 1, entry 14); therefore, 10 mol% of TBM
was sufficient (Table 1, entry 6). Among the different
catalysts tested, including pentafluoro phenylammonium
triflate (PFPAT), LiBr, p-toluene sulfonic acid and TBM,
TBM was found to be the most efficient in terms of
product yield (Table 1, entries 6 and 15–17).
To evaluate the scope of this catalytic trans-
formation, the optimized reaction conditions were
subsequently applied to the reaction of 1,3-indanedione,
ethylacetoacetate/methylacetoacetate and ammonium
acetate with a variety of different aromatic aldehydes
(Table 2, entries 1–18). A wide range of aromatic
aldehydes bearing either electron-donating or electron-
withdrawing substituents were reacted successfully with
1,3-indanedione, ethylacetoacetate/methylacetoacetate
and ammonium acetate to give the corresponding 4-
aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine derivatives
in high yields in short reaction times. The elec-
tronic nature and the position of the substituent on
the aromatic aldehydes have only a slight influence
on the yields of 4-aryl-4,5-dihydro-1H-indeno[1,2-
b]pyridines. Aldehydes with electron-withdrawing
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ubstituents provided the desired 4-aryl-4,5-dihydro-
H-indeno[1,2-b]pyridine derivatives in slightly higher
ields (Table 2, entries 2, 3, 4, 8, 9, 11,12, 14, and
6–18), whereas the yields were slightly lower for alde-
ydes with electron-donating substituents (entries 5, 6
nd 15). Aldehydes with ortho-substituents gave slightly
ower yields than those with para-substituents (Table 2,
ntries 7 and 10). Aliphatic aldehydes were not good
ubstrates, and the reactions did not progress. A possi-
le explanation for the better yield under solvent-free-4,5-dihydro-1H-indeno[1,2-b]pyridines.
conditions is that the eutectic mixture with a uniform
distribution of the reactants brings the reacting species
into close proximity to react compared with solvent. It
may be considered that the environment of the reaction
system without solvent is different from that in the solu-
tions, resulting in a higher concentration of local reaction
sites and improving the global efficiency.
A mechanistic rationale portraying the probable
sequence of events for the formation of 4-aryl-4,5-
dihydro-1H-indeno[1,2-b]pyridine using TBM as a
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Table 2
Synthesis of various 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine
derivatives in the presence of TBM (10 mol%).a
Entry R R1 Product Time (min) Yield (%)b
1 4-H C2H5 4a 12 93
2 4-Cl C2H5 4b 8 97
3 3-Br C2H5 4c 8 92
4 3-NO2 C2H5 4d 12 90
5 4-CH3 C2H5 4e 18 88
6 4-OCH3 C2H5 4f 18 88
7 2-Cl C2H5 4g 14 86
8 4-F C2H5 4h 8 94
9 4-NO2 C2H5 4i 8 92
10 2-F C2H5 4j 12 88
11 3-Cl C2H5 4k 10 91
12 4-Br C2H5 4l 8 94
13 4-H CH3 4m 10 94
14 4-NO2 CH3 4n 8 93
15 4-CH3 CH3 4o 18 87
16 4-Cl CH3 4p 8 96
17 4-Br CH3 4q 8 92
18 3-Cl CH3 4r 8 92
a Reaction conditions: benzaldehyde (1 mmol), 1,3-indanedione
(1 mmol), ethylacetoacetate/methylacetoacetate (1 mmol) and ammo-
◦
[9] J. Koyama, I. Morita, N. Kobayashi, T. Osakai, Y. Usukic, M.nium acetate (1.5 mmol) under solvent-free conditions at 70 C.
b Isolated yields.
catalyst is given in Scheme 3. In this reaction, tribro-
momelamine could act as a bifunctional catalyst [25] in
that it would activate both the carbonyl oxygen in the
aldehyde and the acidic hydrogen in 1,3-indanedione.
Because tribromomelamine contains Br atoms that are
attached to N atoms, it is likely that Br+ would be
released in  situ, and this species would act as a
catalyst in the reaction medium, leading to a consid-
erable increase in the electrophilicity of the aldehyde
(intermediate a).
It is proposed that tribromomelamine produces
two different species: (i) N2,N4-dibromo-1,3,5-triazine-
2,4,6-triamine, called TBMH and (ii) the remaining
anions from the release of Br+ from TBM, called TBM−.
The reaction follows the attack of 1,3-indanedione on
the activated carbonyl to afford intermediate (b). The
reaction proceeded until the formation of intermediate
(c). The reaction could be continued via  a Michael addi-
tion and with the formation of intermediates (d), (e),
(f) and (g). The next key intermediate is ester enamine
(h), produced by the condensation of β-ketoester with
ammonia. The condensation of these two fragments,
namely (g) and (h), gives the acyclic Michael adduct
intermediate (i), which gives intermediate (j). Interme-
diate (j) undergoes intramolecular cyclization with the
participation of the amino function and one of the 1,3-
indanedione carbonyl groups with the removal of waterrsity for Science 10 (2016) 709–717
to form 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine as
the targeted molecule.
4.  Conclusions
We developed a facile and efficient one-pot syn-
thesis of 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridine
in the presence of TBM (10 mol%) under solvent-free
conditions at 70 ◦C with high yields. The key step
in our synthetic sequence is the intramolecular con-
densation with the participation of the amino function
and one of the 1,3-indanedione carbonyl groups in the
acyclic intermediate, resulting in ring closure to form
the 4-aryl-4,5-dihydro-1H-indeno[1,2-b]pyridines. The
milder conditions, shorter reaction times, low costs, easy
workup and high yields make this process attractive com-
pared with the other available methods.
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